This Forum session explored a broad range of forward-thinking policy reforms aimed at optimizing the efficiency of the health care system. Three leading experts in health policy—Jerry Avorn, MD, Daniel Callahan, PhD, and David Cutler, PhD—shared their perspectives on the clinical, ethical, and economic shortcomings of the existing system and opportunities for improvement. Alternative scientific, financing, and delivery system constructs were discussed. Federal policy changes to re-align payment incentives, re-prioritize biomedical research objectives, and reframe regulatory roles were also considered.
Jerry Avorn, MD, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, and Professor, Harvard Medical School; Daniel Callahan, PhD, Director of International Programs, The Hastings Center, and Senior Fellow, Harvard Medical School; David Cutler, PhD, Professor, Department of Economics, Kennedy School of Government, and Associate Dean, Faculty of Arts and Sciences for Social Sciences, Harvard University